- Location
intravenous treatment
"-
Health Care Reform Survives a Lawsuit
Jan 21, 2014The New York Times: Health Care Reform Survives A Lawsuit A long-shot lawsuit that could have damaged the effectiveness of health care reform got a well-deserved brushoff from a federal district judge on Wednesday. The suit was brought ...
Tags: New York Times, Alemtuzumab, Maternity Leave, FDA
-
Trevena Announced Today Initiation of Dosing in BLAST-AHF
Jan 10, 2014Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, announced today initiation of dosing in BLAST-AHF, the Company's randomized, multi-center ...
Tags: Trevena, GPCR biased ligands, BLAST-AHF, acute heart failure
-
Ceptaris Therapeutics Has Obtained FDA Marketing Approval for Valchlor
Aug 27, 2013Ceptaris Therapeutics has obtained FDA marketing approval for Valchlor (mechlorethamine) gel to topically treat stage IA and IB mycosis fungoides-type cutaneous T-Cell lymphoma (CTCL) patients who were exposed to skin-directed therapy ...
Tags: Valchlor Gel, Ceptaris
-
Jennerex Starts Phase 2 Hcc Trial of Jx-594
Nov 27, 2012Jennerex has treated the first patient in a Phase 2 clinical trial of intravenous treatment with JX-594 for patients with advanced hepatocellular carcinoma(HCC)who have not received treatment with sorafeni. The ...
Tags: hepatocellular carcinoma, JX-594, intravenous treatment, Jennerex
Related Products
-
Leg Massage Treatment Spray Intravenous Spray
-
Infusion Pump Compact with Accurate and Sefe Infusion
-
Fn-810 Dual Syringe Pump Electric Pump Syringe Infusion Pump Double-Channel
-
GMP Certified / Ceftazidime for Injection 1g
-
Syringe Pump for Ward Curing Hospital Treatment Instruments
-
Syringe Pump Electricpump Medical Instrument One Channel
